Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
ITM2A as a Tumor Suppressor and Its Correlation With PD-L1 in Breast Cancer
Rui Zhang et al.
FRONTIERS IN ONCOLOGY (2021)
PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer
Franziska E. Marquard et al.
BIOCHEMICAL PHARMACOLOGY (2020)
A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction
Menghuang Zhao et al.
INTERNATIONAL JOURNAL OF GENOMICS (2020)
Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis
Le Yu et al.
ONCOGENE (2020)
An NAD+-Dependent Deacetylase SIRT7 Promotes HCC Development Through Deacetylation of USP39
Ling Dong et al.
ISCIENCE (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Reversible regulation of SATB1 ubiquitination by USP47 and SMURF2 mediates colon cancer cell proliferation and tumor progression
Le Yu et al.
CANCER LETTERS (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis
Ling Dong et al.
ONCOGENE (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways
Yuanyuan Li et al.
ONCOTARGET (2017)
Loss of ITM2A, a novel tumor suppressor of ovarian cancer through G2/M cell cycle arrest, is a poor prognostic factor of epithelial ovarian cancer
Thi My Hien Nguyen et al.
GYNECOLOGIC ONCOLOGY (2016)
The integral membrane protein ITM2A, a transcriptional target of PKA-CREB, regulates autophagic flux via interaction with the vacuolar ATPase
Sim Namkoong et al.
AUTOPHAGY (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer
Domenica Lorusso et al.
GYNECOLOGIC ONCOLOGY (2014)
Itm2a, a Target Gene of GATA-3, Plays a Minimal Role in Regulating the Development and Function of T Cells
Tzong-Shyuan Tai et al.
PLOS ONE (2014)
Treatment of metastatic cervical cancer: Future directions involving targeted agents
Ivan Diaz-Padilla et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
γ-secretase inhibition combined with cisplatin enhances apoptosis of nasopharyngeal carcinoma cells
Jun-Xu Zhou et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
Ding-Wu Shen et al.
PHARMACOLOGICAL REVIEWS (2012)
ERCC1 (excision repair cross-complementation group 1) expression as a predictor for response of neoadjuvant chemotherapy for FIGO stage 2B uterine cervix cancer
Jong-Sup Park et al.
GYNECOLOGIC ONCOLOGY (2011)
Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy
Hai-Yan Zhang et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2009)
Heat shock protein 27 protects L929 cells from cisplatin-induced apoptosis by enhancing akt activation and abating suppression of thioredoxin reductase activity
Yong Zhang et al.
CLINICAL CANCER RESEARCH (2007)
Normalization of cDNA microarray data
GK Smyth et al.
METHODS (2003)
Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation
YH Yang et al.
NUCLEIC ACIDS RESEARCH (2002)
Share Paper
